Yield10 Bioscience, Inc. Common Stock
YTEN
YTEN was delisted on the 15th of May, 2024.
10 hedge funds and large institutions have $628K invested in Yield10 Bioscience, Inc. Common Stock in 2019 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 3 closing their positions.
34% more capital invested
Capital invested by funds: $468K → $628K (+$160K)
33% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 3
11% more funds holding
Funds holding: 9 → 10 (+1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$494K |
| 2 |
BC
Birchview Capital
Burlington,
Vermont
|
+$210K |
| 3 |
VF
Virtu Financial
New York
|
+$109K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$55.6K |
| 5 |
Renaissance Technologies
New York
|
+$37.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CC
Cannell & Co
New York
|
-$59K |
| 2 |
GC
GMT Capital
Atlanta,
Georgia
|
-$17K |
| 3 |
Victory Capital Management
San Antonio,
Texas
|
-$1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
BlackRock
New York
| $259K | +$494K | +1,555 | +9,719% |
|
|
BC
2
Birchview Capital
Burlington,
Vermont
| $130K | +$210K | +661 | +512% |
|
|
3
Renaissance Technologies
New York
| $100K | +$37.5K | +118 | +24% |
|
|
VF
4
Virtu Financial
New York
| $57K | +$109K | +344 | New |
|
|
5
Citadel Advisors
Miami,
Florida
| $29K | +$55.6K | +175 | New |
|
6
Vanguard Group
Malvern,
Pennsylvania
| $18K | – | – | – |
|
7
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $16K | +$30.8K | +97 | New |
|
8
Geode Capital Management
Boston,
Massachusetts
| $10K | – | – | – |
|
9
UBS Group
Zurich,
Switzerland
| $7K | +$13.7K | +43 | New |
|
|
HDIM
10
Hanson & Doremus Investment Management
Burlington,
Vermont
| $2K | – | – | – |
|
|
CC
11
Cannell & Co
New York
| – | -$59K | -122 | Closed |
|
|
GC
12
GMT Capital
Atlanta,
Georgia
| – | -$17K | -35 | Closed |
|
|
13
Victory Capital Management
San Antonio,
Texas
| – | -$1K | -2 | Closed |
|
YTEN Hedge Fund Activity: Q4 2019 in Review
10 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Yield10 Bioscience, Inc. Common Stock (YTEN) for Q4 2019, worth a combined $628K — up 34% from $468K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new YTEN positions and 3 closed out — a net gain of 1 holder — while 3 added to existing stakes and 0 trimmed.
The largest buyer was BlackRock, adding an estimated $494K. The largest seller was Cannell & Co, exiting entirely with an estimated $59K sold.
- 10 institutional investors held Yield10 Bioscience, Inc. Common Stock (YTEN) as of Q4 2019, up from 9 in Q3 2019.
- Funds reported $628K of Yield10 Bioscience, Inc. Common Stock stock for Q4 2019, up 34% quarter-over-quarter.
- 4 funds opened new Yield10 Bioscience, Inc. Common Stock positions in Q4 2019 and 3 closed out, a net change of +1 holder.
- The largest Yield10 Bioscience, Inc. Common Stock buyer in Q4 2019 was BlackRock, an estimated $494K added.
- The largest Yield10 Bioscience, Inc. Common Stock seller in Q4 2019 was Cannell & Co, an estimated $59K sold.
Based on aggregated 13F filings for Q4 2019.